头颈癌患者的经济毒性:一项范围综述。
完整摘要 · 中文译文
目的:由于治疗的复杂性和长期的功能后果,经济毒性已成为肿瘤学中的一个重要结局指标,尤其是在头颈癌中。本研究旨在梳理和综合头颈癌患者经济毒性方面的现有证据。 方法:按照乔安娜布里格斯研究所指南开展了一项范围综述。检索了PubMed、Scopus、Embase和Web of Science。在筛选了1,466项研究后,29项符合纳入标准。数据由四名评价者提取,整理为专题矩阵,并使用VOSviewer软件辅以文献计量学分析。 结果:这些发表于2012年至2025年之间的研究表明,经济毒性普遍存在且具有多维性,涉及直接成本(与肿瘤治疗相关的交通、药物、食物和牙科护理)和间接成本(收入损失和缺勤)。低收入、低教育水平、非正规就业、缺乏保险以及距治疗中心较远等因素与经济毒性风险较高相关。这种情况与较差的生活质量、情绪困扰、抑郁症状、焦虑、治疗中断或延迟以及重返工作困难相关。最常用的工具是FACIT-COST,其次是FIT和作者自编问卷。文献计量学分析显示研究集中于高收入国家,并突出了以“经济毒性”、“qualit “生活质量”和“治疗费用”。 结论:财务毒性是头颈癌患者照护中一个相关且多维度的结局,具有重要的心理社会意义。其影响在治疗轨迹中和生活质量方面均十分显著,因此必须将其系统地纳入临床评估。需要加强支持体系和卫生政策,整合财务、社会和心理支持,以减少不平等并促进肿瘤照护获取方面的公平。
完整摘要 · 英文原文
OBJECTIVE: Financial toxicity has emerged as an important outcome in oncology, particularly in head and neck cancer, due to therapeutic complexity and prolonged functional consequences. This study aimed to map and synthesize the available evidence on financial toxicity in patients with head and neck cancer. METHODS: A scoping review was conducted in accordance with the Joanna Briggs Institute guidelines. Searches were performed in PubMed, Scopus, Embase, and Web of Science. After screening 1,466 studies, 29 met the eligibility criteria. Data were extracted by four reviewers, organized into a thematic matrix, and complemented by a bibliometric analysis using VOSviewer software. RESULTS: The studies, published between 2012 and 2025, showed that financial toxicity is frequent and multidimensional, involving direct costs (transportation, medications, food, and dental care related to oncological treatment) and indirect costs (loss of income and work absence). Factors such as low income, low educational level, informal employment, lack of insurance, and greater distance from treatment centers were associated with a higher risk of financial toxicity. This condition was associated with poorer quality of life, emotional distress, depressive symptoms, anxiety, treatment interruption or delay, and difficulties in returning to work. The most commonly used instrument was FACIT-COST, followed by FIT and author-developed questionnaires. Bibliometric analysis showed a concentration of studies in high-income countries and highlighted conceptual axes centered on "financial toxicity," "quality of life," and "treatment costs". CONCLUSION: Financial toxicity represents a relevant and multidimensional outcome in the care of patients with head and neck cancer, with important psychosocial implications. Its impacts are significant along the therapeutic trajectory and on quality of life, making its systematic inclusion in clinical assessment essential. There is a need to strengthen support systems and health policies that integrate financial, social, and psychological support, aiming to reduce inequalities and promote equity in access to oncological care.